Evidence map›Paper›PMID 32349998›Full record

ReviewClinical microbiology reviews2020

Antifungal Susceptibility Testing: Current Approaches.

Elizabeth L Berkow, Shawn R Lockhart, Luis Ostrosky-Zeichner

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 182 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Breakpoints for the Classification of Anti-BioMed research international · 2021
    Pooled it
  5. Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Guideline
  6. Beyond Species Identification: Clinical Implications ofAnnals of laboratory medicine · 2026
    Article
  7. Article
  8. Article
  9. Rapid antifungal susceptibility testing from positive blood cultures using direct gradient diffusion: a prospective study.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Observational
  10. Data-driven optimization of siderophore fermentation byApplied and environmental microbiology · 2026
    Article
  11. Evaluation of Antimicrobial Activity, Toxicity, and Stability ofJournal of microbiology and biotechnology · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Expression Profiling and Molecular Modeling Analysis ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  18. Article
  19. Article
  20. Article

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elizabeth L BerkowMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA kuu4@cdc.gov.
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Luis Ostrosky-ZeichnerDivision of Infectious Diseases, University of Texas Health Science Center, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility testing (AFST) is a tool of increasing importance in clinical microbiology laboratories. The goal of AFST is to reliably produce MIC values that may be used to guide patient therapy, inform epidemiological studies, and track rates of antifungal drug resistance. There are three methods that have been standardized by standards development organizations: broth dilution, disk diffusion, and azole agar screening for

Indexed as

Antifungal AgentsAspergillus fumigatusCandidaClinical Laboratory TechniquesDrug Resistance, FungalHumansMicrobial Sensitivity TestsMycosesPredictive Value of TestsAntifungal Agentsantifungal resistanceantifungal susceptibility testingbreakpointsCLSIepidemiological cutoff valueEUCAST

Identifiers

PMID32349998
PMCPMC7194854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.